AR128100A1 - Compuestos para el tratamiento de la pérdida del cabello - Google Patents
Compuestos para el tratamiento de la pérdida del cabelloInfo
- Publication number
- AR128100A1 AR128100A1 ARP220103581A ARP220103581A AR128100A1 AR 128100 A1 AR128100 A1 AR 128100A1 AR P220103581 A ARP220103581 A AR P220103581A AR P220103581 A ARP220103581 A AR P220103581A AR 128100 A1 AR128100 A1 AR 128100A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- compounds
- hair loss
- represented
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 201000004384 Alopecia Diseases 0.000 title 1
- 208000024963 hair loss Diseases 0.000 title 1
- 230000003676 hair loss Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163294775P | 2021-12-29 | 2021-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128100A1 true AR128100A1 (es) | 2024-03-27 |
Family
ID=85157456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220103581A AR128100A1 (es) | 2021-12-29 | 2022-12-26 | Compuestos para el tratamiento de la pérdida del cabello |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250163045A1 (enExample) |
| EP (1) | EP4457226A1 (enExample) |
| JP (1) | JP2025502850A (enExample) |
| KR (1) | KR20240129011A (enExample) |
| CN (1) | CN118829641A (enExample) |
| AR (1) | AR128100A1 (enExample) |
| AU (1) | AU2022425460A1 (enExample) |
| CA (1) | CA3244825A1 (enExample) |
| IL (1) | IL314007A (enExample) |
| MX (1) | MX2024008333A (enExample) |
| TW (1) | TW202333692A (enExample) |
| WO (1) | WO2023129854A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12649736B2 (en) | 2019-12-20 | 2026-06-09 | The Regents Of The University Of California | Synthesis of compounds to promote hair growth |
| EP4172159A4 (en) | 2020-06-30 | 2024-01-10 | The Regents of the University of California | Compositions and methods for modulating hair growth |
| CN121005682A (zh) * | 2024-05-24 | 2025-11-25 | 上海医药工业研究院有限公司 | 一种2-苯基-吡咯类化合物、其制备方法及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL321754A (en) | 2017-06-30 | 2025-08-01 | Univ California | Compositions and methods for modulating hair growth |
| MX2021008089A (es) * | 2019-01-02 | 2021-08-05 | Univ California | Composiciones y metodos para modular el crecimiento del cabello. |
| EP4172159A4 (en) * | 2020-06-30 | 2024-01-10 | The Regents of the University of California | Compositions and methods for modulating hair growth |
| EP4172158A4 (en) * | 2020-06-30 | 2024-01-10 | The Regents of the University of California | Compositions and methods for modulating hair growth |
-
2022
- 2022-12-21 CN CN202280092697.2A patent/CN118829641A/zh active Pending
- 2022-12-21 KR KR1020247025466A patent/KR20240129011A/ko active Pending
- 2022-12-21 IL IL314007A patent/IL314007A/en unknown
- 2022-12-21 JP JP2024540042A patent/JP2025502850A/ja active Pending
- 2022-12-21 EP EP22851363.6A patent/EP4457226A1/en active Pending
- 2022-12-21 AU AU2022425460A patent/AU2022425460A1/en active Pending
- 2022-12-21 CA CA3244825A patent/CA3244825A1/en active Pending
- 2022-12-21 MX MX2024008333A patent/MX2024008333A/es unknown
- 2022-12-21 US US18/725,739 patent/US20250163045A1/en active Pending
- 2022-12-21 WO PCT/US2022/082185 patent/WO2023129854A1/en not_active Ceased
- 2022-12-26 TW TW111149987A patent/TW202333692A/zh unknown
- 2022-12-26 AR ARP220103581A patent/AR128100A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118829641A (zh) | 2024-10-22 |
| CA3244825A1 (en) | 2023-07-06 |
| WO2023129854A1 (en) | 2023-07-06 |
| IL314007A (en) | 2024-08-01 |
| TW202333692A (zh) | 2023-09-01 |
| MX2024008333A (es) | 2024-08-30 |
| KR20240129011A (ko) | 2024-08-27 |
| EP4457226A1 (en) | 2024-11-06 |
| US20250163045A1 (en) | 2025-05-22 |
| AU2022425460A1 (en) | 2024-07-18 |
| JP2025502850A (ja) | 2025-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY2240956A (es) | Nuevos Compuestos bicíclicos y sus usos | |
| CO2026005655A2 (es) | Inhibidor de pan-kras y uso del mismo en medicinas | |
| MX2021011606A (es) | Compuestos dirigidos a prmt5. | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| CO2021014210A2 (es) | Compuestos de pirrol | |
| ECSP22083772A (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
| ECSP11011561A (es) | Derivados aminobutíricos sustituidos como inhibidores de neprilisina | |
| DOP2025000146A (es) | Compuesto quimérico protac, método de preparación del mismo y uso del mismo | |
| AR127470A1 (es) | Inhibidores de lrrk2 | |
| MX2021006724A (es) | Compuestos de halo-alilamina y uso de los mismos. | |
| MX2022011240A (es) | Azálidos de urea inmunomoduladores. | |
| MX2024008333A (es) | Compuestos para tratamiento de pérdida de cabello. | |
| CO2025003099A2 (es) | Compuestos para el tratamiento del cáncer | |
| EP4635494A3 (en) | AMIDO HETERO-ROMATIC COMPOUNDS | |
| AR127496A1 (es) | Compuestos de cd73 | |
| DOP2025000090A (es) | Métodos de tratamiento del cáncer usando derivados de isoquinolina o 6-aza-quinolina | |
| AR125479A1 (es) | Inhibidores de il4i1 y métodos de uso | |
| DOP2022000073A (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| AR087346A1 (es) | Formulaciones de compuestos de tiofeno | |
| AR119317A1 (es) | Un derivado de tetrahidroisoquinolina sustituido como modulador alostérico positivo de d1 | |
| CL2025002792A1 (es) | Compuesto y una composición farmacéutica para la prevención o el tratamiento del cáncer o tumores | |
| MX2025009605A (es) | Sal de derivado de anillo heteroaromatico de benzo-nitrogeno, forma cristalina y uso farmaceutico de la misma | |
| MX2025001642A (es) | Tratamiento del cancer de piel | |
| MX2022015532A (es) | Inhibidores selectivos de hdac6 y usos de los mismos. | |
| AR130303A1 (es) | Compuestos de pirazolilsulfonamida y su uso terapéutico |